Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP-001 prophylaxis for Influenza A challenge
NCT03220048Phase 2Completed
- Sponsor
- hVIVO
- Start
- Sep 2015
- Primary completion
- Feb 2016
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of polyinosine-polycytidylic acid in Influenza A (IAV), sponsored by hVIVO. Started Sep 2015; status: completed.
02
Drugs
polyinosine-polycytidylic acid
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT03220048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03220048.